0,869  0,004  Caspase 9 stimulant
0,823  0,007  Antineoplastic (lung cancer)
0,820  0,004  Caspase 3 stimulant
0,803  0,005  Prostate cancer treatment
0,813  0,015  Apoptosis agonist
0,782  0,008  Antineoplastic (colorectal cancer)
0,777  0,005  Antineoplastic (melanoma)
0,776  0,008  Antineoplastic (colon cancer)
0,768  0,008  Antileukemic
0,752  0,004  Antimitotic
0,758  0,013  Antineoplastic (breast cancer)
0,745  0,004  Tubulin antagonist
0,709  0,009  Antineoplastic (ovarian cancer)
0,684  0,006  Antineoplastic (non-small cell lung cancer)
0,675  0,008  Antineoplastic (cervical cancer)
0,661  0,005  Antineoplastic (brain cancer)
0,647  0,010  5 Hydroxytryptamine release stimulant
0,636  0,006  Antineoplastic (multiple myeloma)
0,632  0,007  Antineoplastic (glioma)
0,629  0,005  Antineoplastic (glioblastoma multiforme)
0,617  0,009  Nitric oxide antagonist
0,607  0,003  Alpha tubulin antagonist
0,596  0,009  CYP2C19 inhibitor
0,585  0,012  Hepatic disorders treatment
0,571  0,007  Antineoplastic (carcinoma)
0,567  0,005  Antineoplastic (squamous cell carcinoma)
0,557  0,005  Hepatoprotectant
0,553  0,014  NOS2 expression inhibitor
0,540  0,011  Hypoxia-inducible factor 1 alpha inhibitor
0,531  0,008  Platelet aggregation inhibitor
0,530  0,008  Antineoplastic (renal cancer)
0,554  0,037  Transcription factor NF kappa B inhibitor
0,522  0,009  Psychostimulant
0,510  0,011  Antineoplastic (lymphoma)
0,505  0,027  Vasodilator, peripheral
0,496  0,023  Spasmolytic
0,482  0,018  Vasodilator, coronary
0,480  0,021  Chemopreventive
0,488  0,033  Histamine release inhibitor
0,453  0,004  Neurotrophic factor enhancer
0,441  0,006  Liver fibrosis treatment
0,447  0,012  P-glycoprotein inhibitor
0,461  0,026  Antineoplastic (pancreatic cancer)
0,431  0,004  Neurotrophic factor
0,433  0,014  Antineoplastic (lymphocytic leukemia)
0,452  0,050  CYP3A4 substrate
0,438  0,036  Antihypercholesterolemic
0,450  0,050  Antiprotozoal
0,424  0,029  Sensitization
0,418  0,025  DNA damaging
0,455  0,066  Alzheimer's disease treatment
0,430  0,045  Angiogenesis inhibitor
0,408  0,024  Cardiodepressant
0,405  0,033  Cytostatic
0,383  0,011  Topoisomerase II inhibitor
0,382  0,011  VCAM1 expression inhibitor
0,385  0,026  Antineoplastic (liver cancer)
0,376  0,018  Muscle relaxant
0,372  0,016  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,384  0,038  Antioxidant
0,356  0,014  Skeletal muscle relaxant
0,355  0,014  Pneumotoxic
0,358  0,024  Cyclic AMP phosphodiesterase inhibitor
0,373  0,040  Cytotoxic
0,424  0,092  Antineoplastic (solid tumors)
0,384  0,053  Antithrombotic
0,366  0,035  Antipyretic
0,359  0,030  Antineoplastic (small cell lung cancer)
0,356  0,032  Vasodilator
0,367  0,047  CYP1A2 substrate
0,350  0,030  Sigma receptor agonist
0,344  0,026  Abortion inducer
0,345  0,027  5 Hydroxytryptamine uptake stimulant
0,392  0,081  TNF expression inhibitor
0,381  0,069  CYP2C9 substrate
0,363  0,055  ICAM1 expression inhibitor
0,360  0,053  Respiratory analeptic
0,345  0,040  Free radical scavenger
0,315  0,010  Topoisomerase I inhibitor
0,336  0,042  Tumour necrosis factor alpha release inhibitor
0,378  0,084  15-Lipoxygenase inhibitor
0,322  0,028  Anesthetic general
0,345  0,054  CYP3A4 inhibitor
0,297  0,008  LDLR expression enhancer
0,325  0,040  Amyloid beta aggregation inhibitor
0,320  0,036  GST M1-1 substrate
0,303  0,021  Melanin inhibitor
0,413  0,132  Antiinflammatory
0,315  0,035  Antineoplastic (sarcoma)
0,278  0,005  Postmenopausal disorders treatment
0,326  0,061  Analeptic
0,315  0,050  Antiprotozoal (Leishmania)
0,267  0,005  Microtubule formation inhibitor
0,277  0,019  Genotoxic
0,271  0,014  Platelet activating factor antagonist
0,325  0,069  Apoptosis antagonist
0,262  0,009  Breast cancer-resistant protein inhibitor
0,268  0,014  Carcinogenic, group 1
0,269  0,027  Acaricide
0,244  0,003  Endothelin receptor antagonist
0,265  0,029  Antiviral (Herpes)
0,241  0,005  Beta tubulin antagonist
0,243  0,022  Acetylcholinesterase inhibitor
0,280  0,059  Proliferative diseases treatment
0,295  0,075  CYP2D6 inhibitor
0,267  0,047  Antiparkinsonian, rigidity relieving
0,240  0,020  CDC-like kinase 1 inhibitor
0,237  0,023  Antineoplastic (bone cancer)
0,329  0,115  Antibacterial
0,294  0,081  Antimycobacterial
0,225  0,012  Cyclooxygenase 3 inhibitor
0,221  0,009  Antineoplastic alkaloid
0,215  0,003  Endothelin B receptor antagonist
0,216  0,005  CDC-like kinase 3 inhibitor
0,228  0,020  ATPase inhibitor
0,240  0,032  Restenosis treatment
0,270  0,064  Platelet antagonist
0,206  0,003  Endothelin A receptor antagonist
0,251  0,049  Platelet adhesion inhibitor
0,231  0,034  Amylase inhibitor
0,292  0,096  Cholesterol antagonist
0,251  0,056  Antihypertriglyceridemic
0,201  0,015  Topoisomerase II alpha inhibitor
0,252  0,065  DNA synthesis inhibitor
0,280  0,096  Bone diseases treatment
0,276  0,093  CYP2D6 substrate
0,186  0,005  Estrogen receptor beta agonist
0,269  0,088  Lipoxygenase inhibitor
0,190  0,011  Carcinogenic, group 2A
0,249  0,073  Cardiovascular analeptic
0,190  0,015  Calcium antagonist
0,210  0,043  VEGF expression inhibitor
0,175  0,009  Estrogen agonist
0,253  0,089  Antiosteoporotic
0,192  0,037  Phosphodiesterase inhibitor
0,228  0,074  Antihypotensive
0,185  0,038  Antifungal enhancer
0,253  0,106  CTGF expression inhibitor
0,219  0,075  RNA-directed DNA polymerase inhibitor
0,169  0,025  Bronchodilator
0,231  0,089  Hypoglycemic
0,165  0,023  Papain-like protease (SARS coronavirus) inhibitor
0,217  0,076  Antiparasitic
0,149  0,011  Phosphodiesterase XI inhibitor
0,149  0,011  Phosphodiesterase 11A inhibitor
0,161  0,024  Alpha 2 adrenoreceptor antagonist
0,145  0,009  ATPase (Vacuolar H+) inhibitor
0,247  0,112  Antifungal
0,184  0,049  Antiparkinsonian, tremor relieving
0,159  0,027  Antineoplastic (uterine cancer)
0,180  0,050  Protein kinase stimulant
0,180  0,053  Arachidonic acid antagonist
0,166  0,039  Alkylator
0,237  0,111  Antihypoxic
0,142  0,017  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,142  0,018  Estrogen receptor beta antagonist
0,131  0,009  Antiviral (Hepatitis A)
0,125  0,004  Acetyl-CoA transferase 2 inhibitor
0,145  0,025  Estrogen antagonist
0,266  0,147  Antipruritic, allergic
0,152  0,034  Expectorant
0,177  0,059  UGT2B10 substrate
0,176  0,058  Cholinergic
0,132  0,015  Phosphodiesterase V inhibitor
0,149  0,033  Mucolytic
0,121  0,006  Antitreponemal
0,200  0,088  Nitric-oxide synthase stimulant
0,145  0,038  Antiviral (Papilloma)
0,143  0,036  Alpha 2c adrenoreceptor antagonist
0,186  0,079  Sedative
0,112  0,006  Glutamate (mGluR7) antagonist
0,220  0,116  CYP1A2 inhibitor
0,148  0,046  Antitussive
0,121  0,018  Phosphodiesterase 5A inhibitor
0,217  0,116  CYP2C19 substrate
0,200  0,099  Antiamyloidogenic
0,245  0,144  Antiprotozoal (Plasmodium)
0,136  0,039  Butyrylcholinesterase inhibitor
0,230  0,133  AR expression inhibitor
0,172  0,076  Male reproductive disfunction treatment
0,118  0,026  Inducible nitric-oxide synthase inhibitor
0,158  0,068  Interferon gamma antagonist
0,213  0,124  UGT2B4 substrate
0,230  0,141  Antineoplastic (osteosarcoma)
0,182  0,093  Insulin sensitizer
0,204  0,117  Antiprotozoal (Trypanosoma)
0,089  0,005  Ryanodine receptor antagonist
0,171  0,088  Antihelmintic
0,111  0,028  Histidine decarboxylase inhibitor
0,142  0,060  Skin whitener
0,117  0,038  Antihypermotility
0,166  0,088  Carcinogenic
0,117  0,039  Antineoplastic antibiotic
0,111  0,035  Phosphodiesterase 6D inhibitor
0,158  0,082  UGT2B7 substrate
0,151  0,075  Antimutagenic
0,257  0,183  Alpha-glucosidase inhibitor
0,135  0,062  Antiseptic
0,145  0,072  Adenylate cyclase stimulant
0,102  0,031  mTOR complex 2 inhibitor
0,153  0,082  Uterine stimulant
0,103  0,033  Opioid kappa receptor antagonist
0,118  0,050  Electron transport complex I inhibitor
0,151  0,085  Mutagenic
0,128  0,062  Antiviral (Hepatitis B)
0,159  0,095  Phobic disorders treatment
0,146  0,082  UGT2B9 substrate
0,090  0,028  Phosphodiesterase VI inhibitor
0,141  0,084  Heat shock protein 90 antagonist
0,199  0,146  Antidepressant
0,147  0,094  Interleukin 6 antagonist
0,089  0,037  Estrogen receptor alpha antagonist
0,078  0,027  Exportin-1 inhibitor
0,113  0,062  DNA intercalator
0,112  0,064  Alpha 2b adrenoreceptor antagonist
0,135  0,088  Antiviral (Influenza A)
0,118  0,071  Antiviral (Influenza B)
0,181  0,139  Lipoprotein disorders treatment
0,122  0,082  Antihemorrhagic
0,105  0,065  AMP-activated protein kinase stimulant
0,099  0,060  UGT2B11 substrate
0,096  0,059  Alpha adrenoreceptor antagonist
0,084  0,050  Glycine receptor antagonist
0,050  0,017  Estrogen receptor alpha agonist
0,044  0,012  Tubulin agonist
0,056  0,025  Topoisomerase II beta inhibitor
0,102  0,071  GST T1-1 substrate
0,055  0,024  Factor III inhibitor
0,063  0,035  Heat shock protein 90 beta antagonist
0,118  0,092  Vanilloid 1 agonist
0,139  0,114  Tumour necrosis factor antagonist
0,103  0,079  Activin receptor-like kinase 4 inhibitor
0,215  0,191  Calcium channel activator
0,167  0,145  5 Hydroxytryptamine 3E antagonist
0,111  0,089  Antifungal (Pneumocystis)
0,100  0,078  Multidrug resistance-associated protein 1 inhibitor
0,081  0,062  T cell inhibitor
0,122  0,104  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,131  0,114  Heat shock protein 70 antagonist
0,187  0,169  Mood disorders treatment
0,111  0,095  NADPH oxidase inhibitor
0,085  0,070  Paget's disease treatment
0,139  0,124  Clk dual-specificity kinase inhibitor
0,094  0,079  Antiprotozoal (Toxoplasma)
0,142  0,129  UGT1A1 substrate
0,192  0,179  Antihypertensive
0,096  0,083  DOPA decarboxylase inhibitor
0,046  0,033  Phosphodiesterase 6C inhibitor
0,073  0,060  Keratolytic
0,055  0,043  Postcoital contraceptive
0,108  0,098  Bone formation stimulant
0,025  0,016  Sodium/glucose cotransporter 1 inhibitor
0,059  0,051  Dopamine D1 antagonist
0,086  0,078  Carcinogenic, group 2B
0,145  0,137  Antirickettsial
0,079  0,072  Vanilloid agonist
0,105  0,098  Alcohol dehydrogenase substrate
0,112  0,106  UGT2B15 substrate
0,043  0,037  Microtubule stabilization
0,074  0,068  Phosphodiesterase IV inhibitor
0,025  0,020  Sodium/glucose cotransporter inhibitor
0,164  0,162  Radioprotector
0,106  0,103  Erectile dysfunction treatment
0,024  0,022  Sodium/glucose cotransporter 2 inhibitor
0,127  0,124  Cystic fibrosis treatment
0,028  0,026  Phosphodiesterase 6B inhibitor
0,090  0,088  Choleretic
0,108  0,107  Lipid peroxidase inhibitor
0,056  0,055  Bcl-xL inhibitor
0,059  0,059  Transcription factor RelA inhibitor

